colorectal cancer liver metastasis
Recently Published Documents


TOTAL DOCUMENTS

226
(FIVE YEARS 87)

H-INDEX

23
(FIVE YEARS 4)

2022 ◽  
Vol 11 ◽  
Author(s):  
Yun Wang ◽  
Lu-Yao Ma ◽  
Xiao-Ping Yin ◽  
Bu-Lang Gao

Colorectal cancer is one common digestive malignancy, and the most common approach of blood metastasis of colorectal cancer is through the portal vein system to the liver. Early detection and treatment of liver metastasis is the key to improving the prognosis of the patients. Radiomics and radiogenomics use non-invasive methods to evaluate the biological properties of tumors by deeply mining the texture features of images and quantifying the heterogeneity of metastatic tumors. Radiomics and radiogenomics have been applied widely in the detection, treatment, and prognostic evaluation of colorectal cancer liver metastases. Based on the imaging features of the liver, this paper reviews the current application of radiomics and radiogenomics in the diagnosis, treatment, monitor of disease progression, and prognosis of patients with colorectal cancer liver metastases.


2021 ◽  
pp. canres.2269.2021
Author(s):  
Hossein Sendi ◽  
Mostafa Yazdimamaghani ◽  
Mengying Hu ◽  
Nikhila Sultanpuram ◽  
Jie Wang ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Jun Han ◽  
Jing Zhang ◽  
Chengliang Zhang

The hepatotoxicity of irinotecan is drawing wide concern nowadays due to the widespread use of this chemotherapeutic against various solid tumors, particularly metastatic colorectal cancer. Irinotecan-induced hepatotoxicity mainly manifests as transaminase increase and steatosis with or without transaminase increase, and is accompanied by vacuolization, and lobular inflammation. Irinotecan-induced steatohepatitis (IIS) increases the risk of morbidity and mortality in patients with colorectal cancer liver metastasis (CRCLM). The major risks and predisposing factors for IIS include high body mass index (BMI) or obesity, diabetes, and high-fat diet. Mitochondrial dysfunction and autophagy impairment may be involved in the pathogenesis of IIS. However, there is currently no effective preventive or therapeutic treatment for this condition. Thus, the precise mechanisms underlying the pathogenesis of IIS should be deciphered for the development of therapeutic drugs. This review summarizes the current knowledge and research progress on IIS.


Author(s):  
Areti‐Maria Vasilogianni ◽  
Zubida M. Al‐Majdoub ◽  
Brahim Achour ◽  
Sheila Annie Peters ◽  
Amin Rostami‐Hodjegan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document